HIGHLIGHTS
- who: Marcel Martin and collaborators from the Department of Chemistry-TRIGA Site, Johannes Gutenberg University Mainz, Mainz, Germany have published the research work: Novel Generation of FAP Inhibitor-Based Homodimers for Improved Application in Radiotheranostics, in the Journal: (JOURNAL)
- what: Radioligand therapy (RLT) with radiometals such as lutetium-177 is the main objective of these new dimers.
- how: The new FAPi dimers were tested for their in_vitro affinity for FAP as well as PREP DPP4 DPP8 and DPP9.
SUMMARY
The actual in_vivo role of FAP is not fully understood . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.